Skip to main content

and
  1. Article

    Open Access

    Erianin inhibits the progression of triple-negative breast cancer by suppressing SRC-mediated cholesterol metabolism

    Triple-negative breast cancer (TNBC) is highly malignant and lacks effective biotherapeutic targets. The development of efficient anticancer drugs with low toxicity and few side effects is a hotspot in TNBC tr...

    Ming Li, Shiyao Kang, Xuming Deng, Huimin Li, Yuan Zhao in Cancer Cell International (2024)